Lei‐Lei Wu

965 total citations · 1 hit paper
64 papers, 554 citations indexed

About

Lei‐Lei Wu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Lei‐Lei Wu has authored 64 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 22 papers in Oncology. Recurrent topics in Lei‐Lei Wu's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Esophageal Cancer Research and Treatment (13 papers). Lei‐Lei Wu is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Esophageal Cancer Research and Treatment (13 papers). Lei‐Lei Wu collaborates with scholars based in China, United States and United Kingdom. Lei‐Lei Wu's co-authors include Yue Liu, Shi-Ping Lu, Liang Yang, Lixue Yang, Guowei Ma, Dong Xie, Hao Long, Xuan Liu, Lihong Qiu and Zhixin Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

In The Last Decade

Lei‐Lei Wu

58 papers receiving 547 citations

Hit Papers

The diversified role of mitochondria in ferroptosis in ca... 2023 2026 2024 2025 2023 50 100 150 200

Peers

Lei‐Lei Wu
Meng Sun China
Xiao Zhou China
Lizhe Zhu China
Meng Sun China
Lei‐Lei Wu
Citations per year, relative to Lei‐Lei Wu Lei‐Lei Wu (= 1×) peers Meng Sun

Countries citing papers authored by Lei‐Lei Wu

Since Specialization
Citations

This map shows the geographic impact of Lei‐Lei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei‐Lei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei‐Lei Wu more than expected).

Fields of papers citing papers by Lei‐Lei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei‐Lei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei‐Lei Wu. The network helps show where Lei‐Lei Wu may publish in the future.

Co-authorship network of co-authors of Lei‐Lei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lei‐Lei Wu. A scholar is included among the top collaborators of Lei‐Lei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei‐Lei Wu. Lei‐Lei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yanqin, Tong Wei, Yintao Wang, et al.. (2024). Conditional Overexpression of Net1 Enhances the Trans‐Differentiation of Lgr5+ Progenitors into Hair Cells in the Neonatal Mouse Cochlea. Cell Proliferation. 58(4). e13787–e13787.
2.
Lin, Jiewei, Yang Zhou, Lei‐Lei Wu, et al.. (2024). Antitumor effects of a Sb-rich polyoxometalate on non-small-cell lung cancer by inducing ferroptosis and apoptosis. Chemical Science. 15(37). 15367–15376. 2 indexed citations
3.
Li, Kun, Lei‐Lei Wu, Zi Fu, et al.. (2024). Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy. Journal of Nanobiotechnology. 22(1). 546–546. 18 indexed citations
4.
Qian, Jiayi, Lei‐Lei Wu, Liyan Zhang, et al.. (2023). Prognostic evaluation of stage I lung adenocarcinoma based on systematic inflammatory response. JNCI Cancer Spectrum. 7(6). 3 indexed citations
5.
Wu, Lei‐Lei, Lihong Qiu, Xiaolu Chen, et al.. (2023). Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort. Respiratory Research. 24(1). 168–168. 3 indexed citations
6.
Jiang, Shutan, Hongye Wang, Shaoshuai Mao, et al.. (2023). 58 Epigenetic editing as a promising strategy to enhance efficacy and genomic integrity of CAR T cell therapy. SHILAP Revista de lepidopterología. A67–A68.
7.
Qian, Jiayi, Haihong Yu, Lei‐Lei Wu, et al.. (2023). A Novel Systematic Oxidative Stress Score Predicts the Survival of Patients with Early-Stage Lung Adenocarcinoma. Cancers. 15(6). 1718–1718. 9 indexed citations
9.
Wu, Lei‐Lei, Wenmei Jiang, Jiayi Qian, et al.. (2023). High-risk characteristics of pathological stage I lung adenocarcinoma after resection: patients for whom adjuvant chemotherapy should be performed. Heliyon. 9(12). e23207–e23207. 4 indexed citations
10.
Liu, Yue, Fei Wang, Shibo Yu, et al.. (2023). Deciphering the role of QPCTL in glioma progression and cancer immunotherapy. Frontiers in Immunology. 14. 1166377–1166377. 16 indexed citations
11.
Liu, Yue, et al.. (2023). The diversified role of mitochondria in ferroptosis in cancer. Cell Death and Disease. 14(8). 519–519. 245 indexed citations breakdown →
12.
Wu, Lei‐Lei, Wenmei Jiang, Zhiyuan Liu, et al.. (2023). AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research. Discover Oncology. 14(1). 91–91. 2 indexed citations
13.
Li, Zhixin, et al.. (2022). Is VATS approach suitable in re-operations for postoperative hemothorax after pulmonary resection? Data analysis in a big volume thoracic center. Journal of Cardiothoracic Surgery. 17(1). 310–310. 2 indexed citations
14.
Wu, Lei‐Lei, Chongwu Li, Kun Li, et al.. (2022). The Difference and Significance of Parietal Pleura Invasion and Rib Invasion in Pathological T Classification With Non-Small Cell Lung Cancer. Frontiers in Oncology. 12. 878482–878482. 7 indexed citations
15.
Wu, Lei‐Lei, et al.. (2021). Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery. BMC Cancer. 21(1). 847–847. 7 indexed citations
16.
Wang, Jinlong, Lei‐Lei Wu, Yunzhe Zhang, Guowei Ma, & Yao Lu. (2021). Establishing a survival prediction model for esophageal squamous cell carcinoma based on CT and histopathological images. Physics in Medicine and Biology. 66(14). 145015–145015. 6 indexed citations
17.
Wu, Lei‐Lei, Chongwu Li, Weikang Lin, Lihong Qiu, & Dong Xie. (2021). Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study. BMC Cancer. 21(1). 1009–1009. 18 indexed citations
18.
Wu, Lei‐Lei, et al.. (2020). Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis. World Journal of Surgical Oncology. 18(1). 322–322. 10 indexed citations
19.
20.
Qian, Yun, Jingping Zhang, Ming Xu, et al.. (2009). A Tailored Target Intervention on Influence Factors of Quality of Life in Chinese Patients with Hypertension. Clinical and Experimental Hypertension. 31(1). 71–82. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026